Analysis of research on the benefits of clinical and economic effectiveness, safety of innovative drug cetuximab in the treatment of colorectal cancer

Journal Title: ScienceRise: Pharmaceutical Science - Year 2019, Vol 0, Issue 2

Abstract

<p><strong>The</strong><strong> </strong><strong>aim</strong> of the work is to analyze and systematize literature data on the benefits of clinical and economic efficiency, safety of cetuximab in the treatment of colorectal cancer.</p><p><strong>Materials and methods.</strong> Studies were conducted using databases on the Internet: PubMed; Food and Drug Administration, European Medicines Agency. It has used retrospective, logical, statistical and system-analytical research methods.<strong></strong></p><p><strong>Results.</strong> The analysis of clinical data suggests additional utility, high efficacy of cetuximab in the treatment of patients with metastatic colorectal cancer RAS wild type and expression of epidermal growth factor receptors EGFR compared to other drugs. Cetuximab exhibits a synergistic effect with a number of cytostatic drugs, and also increases the effect of radiotherapy, with no increased toxic reactions when co-administered. The administration of cetuximab in the treatment regimen increases the resectability of primary nonresectable metastases in the liver, as well as survival without progression in both operated patients and in inoperable cases. The drug is considered relatively safe. Skin rashes caused by cetuximab are associated with a significant improvement in overall survival, progression-free survival and overall response rates. The use of cetuximab in patients with colorectal cancer is accompanied by a lower economic burden on the budget of drug provision for cancer patients than bevacizumab. It should be noted that the development of cetuximab biosimilars will reduce the cost of treatment and improve access to colorectal cancer therapy.</p><p><strong>Conclusions.</strong> Thus, it has been shown that cetuximab is not only a clinically effective and relatively safe drug for the treatment of colorectal cancer, but also demonstrates its cost-effectiveness and additional benefits compared with other drugs, including bevacizumab</p>

Authors and Affiliations

Elena Litvinova

Keywords

Related Articles

Аналіз нормативно-правовового регулювання надання паліативної допомоги в Україні

<p><strong>Метою</strong> дослідження, результати якого наведено у статті, стало здійснення аналізу сучасного стану нормативно-правового регулювання паліативної допомоги в Україні.</p><p>У роботі використано<strong> мето...

Influence of dry extract of brassica olearacea on the morphological structure of the gastric mucosa of rats during an experimental ulcer caused by alcohol-prednisolone mixture

<p><strong>Aim</strong> – study of the effect of cabbage dry extract on the morphological state of the gastric mucosa of rats on the background of an experimental alcohol-prednisolone ulcerative lesion.</p><p><strong>Mat...

Substantiation for the optimal strategy of risk management in marketing communicative activities of pharmaceutical enterprises based on mathematical model approach

Aim. To develop a mathematical model of risk analysis and evaluation in the marketing communication activity of pharmaceutical manufacturing enterprises in promoting a new medicine product under limiting and (or) saving...

The impact of indolinoren on histrotructure of kidney on the glixerroid acute renal failure model

<p>Acute renal failure is one of the most severe conditions of kidney damage. This syndrome is characterized by a sharp decrease in excretory renal function with azotemia and significant violations of water-salt homeosta...

Дослідження компонентів летких фракцій рослинної сировини салату посівного сорту «Лолло Россо»

<p>Рослини є важливим джерелом одержання біологічно активних речовин, які проявляють різноманітну фармакологічну активність. Увагу привертають не лише рослини, які традиційно використовуються з лікувально-профілактичною...

Download PDF file
  • EP ID EP647862
  • DOI 10.15587/2519-4852.2019.165681
  • Views 109
  • Downloads 0

How To Cite

Elena Litvinova (2019). Analysis of research on the benefits of clinical and economic effectiveness, safety of innovative drug cetuximab in the treatment of colorectal cancer. ScienceRise: Pharmaceutical Science, 0(2), 22-27. https://europub.co.uk/articles/-A-647862